MC
NVO

Mirabaud & Cie’s Novo Nordisk NVO Stock Holding History

Mirabaud & Cie’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Hold
14,600
– – 0.28% 35
2026
Q1 		$537K Buy
14,600
+4,600
+46% +$218K 0.22% 40
2025
Q4 		$509K Hold
10,000
– – 0.16% 49
2025
Q3 		$555K Buy
10,000
+2,500
+33% +$146K 0.18% 50
2025
Q2 		$518K Sell
7,500
-140
-2% -$9.52K 0.16% 51
2025
Q1 		$531K Buy
+7,640
New +$631K 0.18% 48

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Mirabaud & Cie's NVO Position: Q2 2026 in Review

Mirabaud & Cie held its Novo Nordisk (NVO) position steady in Q2 2026 at 14,600 shares worth $700K. The position accounts for 0.28% of the portfolio, ranked #35.

Mirabaud & Cie first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mirabaud & Cie held 14,600 shares of Novo Nordisk worth $700K as of Q2 2026.
  • Mirabaud & Cie left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.28% of Mirabaud & Cie's portfolio in Q2 2026, its #35 holding.
  • Mirabaud & Cie first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mirabaud & Cie's 13F filing for Q2 2026, filed 8 Jul 2026.